Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Statistics: New Tokens in 2025 Commonly Fall Below Issue Price, Only 15% of Projects Have FDV Higher Than at TGE

Statistics: New Tokens in 2025 Commonly Fall Below Issue Price, Only 15% of Projects Have FDV Higher Than at TGE

BlockBeatsBlockBeats2025/12/22 16:57
Show original

BlockBeats news, on December 23, according to statistics from Ash (@ahboyash), among the 118 new tokens with TGE in 2025, 84.7% (100/118) have a FDV lower than at the time of TGE. This means that for every 5 newly issued tokens, about 4 currently have a FDV below their initial valuation at issuance. The median FDV of these tokens has dropped by 71% compared to the time of issuance (the median market cap has dropped by 67%). Only 15% of the tokens have seen an increase in FDV compared to the time of TGE.


Among the worst performers, there are 15 tokens that have dropped by more than 90%, including some high-profile projects such as Berachain (-93%), Animecoin (-94%), and Bio Protocol (-93%).


Overall, the total FDV of this batch of tokens has shrunk from $139 billion at listing to the current $54 billion, which means that about $87 billion (59%) of the "on-paper" FDV has evaporated (this calculation does not include projects that have gone to zero).


There are also outstanding performers, most of which were issued in the second half of 2025 with relatively low initial valuations, including Aster (+745%), Yooldo Games (+538%), and Humanity (+323%).

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny